Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

Food for thought Severe trial had first jab on

Message Board Public Reply | Private Reply | Keep | Replies (2)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 154718
(Total Views: 554)
Posted On: 09/21/2021 5:16:07 PM
Avatar
Posted By: Normy
Food for thought

Severe trial had first jab on 9/9. 35 sites recruiting. 40% interim number was 245 patients. We could be at interim jab level easily. It would only take 20 patients per day over the 35 sites. (less than 1 patient per day per site) to be at 40% enrollment already. Thats the rate we were getting with CD12 for so long. I would assume Einstein is moving much faster than our first portion CD12 efforts. They wouldnt call themselves Einstein if they were dummies.

So we could easily be in the 28day treatment window for interim enrollment now. Which would mean preliminary data in say 50 days from now realistically. So somewhere around 2nd week of November for real publishable data. Plus all the time to convert from Portuguese to English. So maybe end of November the way things go.

If Einstein is really a powerful bunch and enrolling at the same clip of 20p/day we would essentially be filled by 10/9. If enrollment is only 1p/site/day we would be fully enrolled by this Sunday. At which point we will be having the discussion about whether we really even want to look at interim. But i assume since the peek is built into the study there is no penalty and we can avoid all those various arguments.


(7)
(0)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  


Yours Truly
Lamont
#1 30.58333 114.26667
#2 39.002744, -77.103470





Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us